ArticleThoracic cancer2020

CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo.

Kun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.